Halogen treatment of heart attack and ischemic injury

Abstract

The present invention relates to the use of halogen compounds, including iodide, and chalcogenide compounds, including iodide, sulfide and selenide, to treat and prevent diseases and injuries. The present invention further relates to compositions comprising a halogen compound and/or a chalcogenide compound, including pharmaceutical compositions, as well as methods of manufacturing such compounds and administering such compositions to subjects in need thereof.

1 . A method for treating or preventing an injury or disease in a subject, comprising providing to said subject a composition comprising a halogen compound and a pharmaceutically acceptable carrier, diluent, or excipient. 
     
     
         2 . (canceled) 
     
     
         3 . The method of  claim 1 , wherein said halogen compound comprises iodine. 
     
     
         4 . (canceled) 
     
     
         5 . The method of  claim 3 , wherein said halogen compound is an iodide. 
     
     
         6 . The method of  claim 5 , wherein said iodide is sodium iodide, potassium iodide, hydrogen iodide, calcium iodide, or silver iodide. 
     
     
         7 .- 10 . (canceled) 
     
     
         11 . The method of  claim 1 , wherein the halogen is present in the halogen compound in a reduced form. 
     
     
         12 . The method of  claim 1 , wherein said composition is provided to the subject parenterally or orally. 
     
     
         13 . The method of  claim 12 , wherein said composition is provided to the subject intravenously or by infusion. 
     
     
         14 . The method of  claim 13 , wherein said composition is formulated for intravenous administration, administration by infusion, or oral administration and wherein the composition comprises a stable reduced form of the halogen compound. 
     
     
         15 . The method of  claim 1 , wherein said composition is provided to the subject in an amount sufficient to increase the blood concentration of the halogen at least 100%, at least 200%, at least 300%, at least 400%, or at least 500% for at least some time. 
     
     
         16 . The method of  claim 1 , wherein said disease or injury is selected from any of the following, or is caused by or results from any of the following: ablation therapy, adrenalectomy, aortic aneurysm, aortic root surgery, aortic stenosis, aortic valve disease, arrhythmia, atherosclerosis, atrial flutter, atrial fibrillation, atrial septal defect, arteriovenous malformation, awake brain surgery, bariatric surgery, bone marrow transplant, brachial plexus injuries, bradycardia, brain aneuryism, breast augmentation surgery, breast reduction surgery, burn injury, coronary bypass surgery, cataract, coronary artery disease, cardiac ablation, cardiac catheterization, cardiac resynchronization therapy, cardiac surgery, cardiomyopathy, cardiac surgery, cardiovascular diseases, carotid angioplasty and stenting, coarctation of the aorta, congenital heart disease, coronary bypass surgery, coronary artery disease, critical care medicine, chronic obstructive pulmonary disease, Ebola virus, elbow replacement surgery, emergency medicine, epilepsy, general internal medicine, general surgery, gastrointestinal bleeding, graft versus host disease, Hanta pulmonary virus (HPV), heart attack, heart transplant, heart valve surgery, hip replacement surgery, hypertrophic cardiomyopathy, hypoxia ischemia encephalopathy, hysterectomy, ileoanal anastomosis (j pouch) surgery, ileus, post-operative ileus, inflammatory bowel disease, ischemic heart disease, ischemia reperfusion injury, irritable bowel syndrome, jaw surgery, kidney transplant, laryngotracheal reconstruction surgery, liver transplant, lung volume reduction surgery, lung transplant, minimally invasive heart surgery, noise-induced hearing loss, neurosurgery, oral and maxillofacial surgery, orthopedic surgery, pancreas transplant, pancreatitis, partial nephrectomy, pediatric cervical spine surgery, pediatric surgery, pelvic organ prolapse, peripheral vascular disease, plastic and reconstructive surgery, pulmonary and critical care medicine, pulmonary atresia, pulmonary vein isolation, radiation-inducd lung injury, rectal prolapse, restrictive cardiomyopathy, retinal detachment, retinopathy of prematurity, robotic surgery,  Salmonella  infection, surgical adhesion, sickle cell anemia, sickle cell crisis, ST segment elevation myocardial infarction (STEMI), stem cell engraftment, spinal cord injury, spontaneous coronary artery dissection, spontaneous occlusion of the circle of willis, stroke, stroke telemedicine (telestroke), sudden cardiac arrest, stereotactic radiosurgery, surgery, chronic heart failure, systolic heart failure, tachycardia, teare's disease, thoracic aortic aneurysm, thoracic surgery, total elbow arthroplasty, tricuspid valve disease, ulcerative colitis, valve-preserving aortic root repair, vascular and endovascular surgery, vascular medicine, ventilator-induced lung injury, or ventricular tachycardia. 
     
     
         17 . The method of  claim 1 , wherein said injury or disease is selected from, results from or is caused by inflammation, immune response, heart attack, coronary bypass surgery, ischemia, gut ischemia, liver ischemia, kidney ischemia, hypoxic-ischemic encephalopathy, stroke, traumatic brain injury, limb ischemia, eye ischemia, sepsis, smoke, burn, reperfusion, or acute lung injury. 
     
     
         18 .- 36 . (canceled) 
     
     
         37 . A composition comprising a halogen compound and a carrier, wherein said halogen compound is associated to said carrier. 
     
     
         38 .- 152 . (canceled) 
     
     
         153 . A method of preventing, inhibiting, or reducing an immune response in a subject, comprising providing a halogen compound and/or a chalcogenide to the subject. 
     
     
         154 .- 172 . (canceled)